Showing results (1701-1710 of 3,638) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|September 16, 2023
Additional intraoperative subpectoral plane block vs conventional pain control: A comparison of shoulder movement in patients with mastectomySivaporn Pondeenana, Chao Saenghirunvattana, Patcharin Intarakhao, et al.
Breast (Edinburgh, Scotland)|September 25, 2024
Financial toxicity in breast cancer patients receiving regional nodal irradiation: Variation by cancer subtypeGrace L Smith, Benjamin D Smith, Chi-Fang Wu, et al.
Breast (Edinburgh, Scotland)|September 12, 2024
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?Rebecca Pedersini, Greta Schivardi, Marta Laganà, et al.
Breast (Edinburgh, Scotland)|September 7, 2024
Stereotactic body radiotherapy using CyberKnife versus interstitial brachytherapy in accelerated partial breast irradiation on left-sided breast: A comparison of dosimetric characteristics and preliminary clinical resultsTing-Na Wei, Jia-Fu Lin, Mei-Chun Cheng, et al.
Breast (Edinburgh, Scotland)|February 28, 2026
Safety and effectiveness of post-trastuzumab deruxtecan regimens in patients with HER2-positive metastatic breast cancer who discontinued trastuzumab deruxtecan due to interstitial lung diseaseJunji Tsurutani, Kazuki Nozawa, Toru Mukohara, et al.
Breast (Edinburgh, Scotland)|March 3, 2026
Real-world treatment patterns and outcomes in HER2-low, HR+ metastatic breast cancer patients previously treated with endocrine therapy in the United StatesShanu Modi, Danalyn Byng, Suyuan Zhang, et al.
Breast (Edinburgh, Scotland)|February 20, 2026
Real-world treatment patterns and sequencing in patients with advanced / metastatic HR+/HER2- breast cancer in Europe and the United StatesReshma Mahtani, Beata Korytowsky, Chloe Grace Rose, et al.
Breast (Edinburgh, Scotland)|February 19, 2026
BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancerTimothé Guinel, Amélie Lusque, Audrey Mailliez, et al.
Breast (Edinburgh, Scotland)|November 23, 2024
Influence of ethnicity on cyclin-dependent kinase inhibitor efficacy and toxicity: A systematic review and meta-analysisRoberto Buonaiuto, Aldo Caltavituro, Margherita Tafuro, et al.
Breast (Edinburgh, Scotland)|November 30, 2024
Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS componentRoxanne A W Ploumen, Thiemo J A van Nijnatten, Loes F S Kooreman, et al.
Pageof 364